Managing Lung Nodules Using Telemedicine and Molecular Biomarkers During the COVID-19 Pandemic

Chest. 2020 Oct;158(4):1794-1795. doi: 10.1016/j.chest.2020.05.574.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • Biomarkers
  • COVID-19
  • Coronavirus Infections*
  • Early Detection of Cancer
  • Humans
  • Lung Neoplasms*
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2
  • Telemedicine*

Substances

  • Biomarkers